(Q43042290)

English

Progression of chronic hepatitis C to liver fibrosis and cirrhosis in patients coinfected with hepatitis C virus and human immunodeficiency virus

scientific article published on 31 January 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

12 November 2017

Progression of chronic hepatitis C to liver fibrosis and cirrhosis in patients coinfected with hepatitis C virus and human immunodeficiency virus (English)

1 reference

Europe PubMed Central

12 November 2017

liver cirrhosis

0 references

Hepatitis C virus

1 reference

based on heuristic

inferred from title

0 references

1 reference

based on heuristic

inferred from title

chronic hepatitis C

1 reference

based on heuristic

inferred from title

chronic hepatitis

1 reference

based on heuristic

inferred from title

author name string

Carmen Martinez-Sierra

1

1 reference

Europe PubMed Central

12 November 2017

Ana Arizcorreta

2

1 reference

Europe PubMed Central

12 November 2017

Fernando Díaz

3

1 reference

Europe PubMed Central

12 November 2017

Rafael Roldán

4

1 reference

Europe PubMed Central

12 November 2017

Leopoldo Martín-Herrera

5

1 reference

Europe PubMed Central

12 November 2017

Eugenio Pérez-Guzmán

6

1 reference

Europe PubMed Central

12 November 2017

José A Girón-González

7

1 reference

Europe PubMed Central

12 November 2017

language of work or name

0 references

publication date

31 January 2003

1 reference

Europe PubMed Central

12 November 2017

Clinical Infectious Diseases

1 reference

Europe PubMed Central

12 November 2017

36

1 reference

Europe PubMed Central

12 November 2017

4

1 reference

Europe PubMed Central

12 November 2017

491-498

1 reference

Europe PubMed Central

12 November 2017

Hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1086%2F367643

21 January 2018

An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group

1 reference

https://api.crossref.org/works/10.1086%2F367643

21 January 2018

Natural history of hepatitis C: its impact on clinical management

1 reference

https://api.crossref.org/works/10.1086%2F367643

21 January 2018

Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups

1 reference

https://api.crossref.org/works/10.1086%2F367643

21 January 2018

Hepatitis C genotypes: the key to pathogenicity?

1 reference

https://api.crossref.org/works/10.1086%2F367643

21 January 2018

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

1 reference

https://api.crossref.org/works/10.1086%2F367643

21 January 2018

Care of patients with chronic hepatitis C and HIV co-infection: recommendations from the HIV-HCV International Panel.

1 reference

https://api.crossref.org/works/10.1086%2F367643

21 January 2018

Influence of human immunodeficiency virus type 1 infection on the natural course of chronic parenterally acquired hepatitis C.

1 reference

https://api.crossref.org/works/10.1086%2F367643

21 January 2018

Human immunodeficiency virus infection modifies the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosis

1 reference

https://api.crossref.org/works/10.1086%2F367643

21 January 2018

The influence of human immunodeficiency virus coinfection on chronic hepatitis C in injection drug users: a long-term retrospective cohort study.

1 reference

https://api.crossref.org/works/10.1086%2F367643

21 January 2018

Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group

1 reference

https://api.crossref.org/works/10.1086%2F367643

21 January 2018

Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: a meta-analysis

1 reference

https://api.crossref.org/works/10.1086%2F367643

21 January 2018

Impact of human immunodeficiency virus infection on the histological features of chronic hepatitis C: a case-control study. The MULTIVIRC group

1 reference

https://api.crossref.org/works/10.1086%2F367643

21 January 2018

Factors affecting liver fibrosis in human immunodeficiency virus-and hepatitis C virus-coinfected patients: impact of protease inhibitor therapy

1 reference

https://api.crossref.org/works/10.1086%2F367643

21 January 2018

Relationship of hepatitis C viremia to HIV state and to infection by specific hepatitis C genotypes

1 reference

https://api.crossref.org/works/10.1086%2F367643

21 January 2018

Antiretroviral therapy in adults: updated recommendations of the International AIDS Society-USA Panel

1 reference

https://api.crossref.org/works/10.1086%2F367643

21 January 2018

Influence of different hepatitis C virus genotypes on the course of asymptomatic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1086%2F367643

21 January 2018

Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1086%2F367643

21 January 2018

Classification of chronic viral hepatitis: a need for reassessment

1 reference

https://api.crossref.org/works/10.1086%2F367643

21 January 2018

Effect of human immunodeficiency virus on hepatitis C virus infection among injecting drug users

1 reference

https://api.crossref.org/works/10.1086%2F367643

21 January 2018

Evolution of coinfection with human immunodeficiency virus and hepatitis C virus in patients treated with highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1086%2F367643

21 January 2018

Hepatitis C virus/human immunodeficiency virus coinfection: clinical management issues

1 reference

https://api.crossref.org/works/10.1086%2F367643

21 January 2018

Factors related to the chronicity and evolution of hepatitis C infection in patients co-infected by the human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1086%2F367643

21 January 2018

Identifiers

1 reference

Europe PubMed Central

12 November 2017

1 reference

Europe PubMed Central

12 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43042290&oldid=1978332847"